Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06641115 · ClinicalTrials.gov registry record · NA

Integrated Treatment for Opioid Use Disorder and PTSD

A NA study of Opioid Use Disorder and Posttraumatic Stress Disorder (PTSD), sponsored by Medical University of South Carolina.

Recruiting
Registry status
NA
Development phase
76
Enrollment target
1
Study location

NCT06641115 is a NA study of Opioid Use Disorder and Posttraumatic Stress Disorder (PTSD) that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 76 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06641115, a NA study of Opioid Use Disorder and Posttraumatic Stress Disorder (PTSD), is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
NA
Development phase
76 participants
Enrollment target
1
Study location

Study Summary

This study will test a therapy intervention, HOPE, for individuals with opioid use disorder and posttraumatic stress disorder. Interested individuals will need to be taking medications for opioid use disorder (e.g., suboxone, naltrexone, methadone). Interested participants will complete a 10-12 week therapy, and be asked to complete surveys.

Interventions

  • BEHAVIORAL HOPE Therapy

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2025-03-01
Est. Completion 2027-08
Phase NA

What the Registry Record Tells You About NCT06641115

The ClinicalTrials.gov registry entry for NCT06641115 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (98% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which HOPE Therapy is the first listed.

NCT06641115 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT06641115 about?

NCT06641115 is a clinical study titled "Integrated Treatment for Opioid Use Disorder and PTSD". This study will test a therapy intervention, HOPE, for individuals with opioid use disorder and posttraumatic stress disorder. Interested individuals will need to be taking medications for opioid use disorder (e.g., suboxone, naltrexone, methadone). Interested participants will complete a 10-12 week...

What is the current status of trial NCT06641115?

This trial is currently recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2025-03-01. Estimated completion is 2027-08.

What conditions does trial NCT06641115 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Posttraumatic Stress Disorder (PTSD).

What interventions are being tested in trial NCT06641115?

The interventions under investigation include: HOPE Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06641115?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06641115 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.